Laurie Herviou

649 total citations
20 papers, 452 citations indexed

About

Laurie Herviou is a scholar working on Molecular Biology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Laurie Herviou has authored 20 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Hematology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Laurie Herviou's work include Histone Deacetylase Inhibitors Research (9 papers), Epigenetics and DNA Methylation (8 papers) and Protein Degradation and Inhibitors (7 papers). Laurie Herviou is often cited by papers focused on Histone Deacetylase Inhibitors Research (9 papers), Epigenetics and DNA Methylation (8 papers) and Protein Degradation and Inhibitors (7 papers). Laurie Herviou collaborates with scholars based in France, United States and Germany. Laurie Herviou's co-authors include Jérôme Moreaux, Giacomo Cavalli, Guillaume Cartron, Bernard Klein, Dai‐Ying Wu, Kimberly D. Siegmund, Rajas Chodankar, Michael R. Stallcup, Danielle Bittencourt and Irina Ianculescu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Oncogene.

In The Last Decade

Laurie Herviou

20 papers receiving 449 citations

Peers

Laurie Herviou

HEMAT

IMMUN

ONCOL

PRM

Kathleen S. Ensbey Australia

Patrick A. Ozark United States

Marisa Gorrese Italy

Anna Zielinska‐Kwiatkowska United States

Benjamin T. Goetz United States

Mathias Jenal Switzerland

Harry Drabkin United States

Hakki Ogün Sercan Türkiye

Lauren Véronèse France

Catherine Carmichael Australia

Kathleen S. Ensbey Australia

Laurie Herviou

251 ×0.7

58 ×0.8

HEMAT

76 ×1.0

IMMUN

138 ×1.9

ONCOL

35 ×0.7

PRM

Citations per year, relative to Laurie Herviou Laurie Herviou (= 1×) peers Kathleen S. Ensbey

Countries citing papers authored by Laurie Herviou

Since Specialization

Citations

This map shows the geographic impact of Laurie Herviou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurie Herviou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurie Herviou more than expected).

Fields of papers citing papers by Laurie Herviou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurie Herviou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurie Herviou. The network helps show where Laurie Herviou may publish in the future.

Co-authorship network of co-authors of Laurie Herviou

This figure shows the co-authorship network connecting the top 25 collaborators of Laurie Herviou. A scholar is included among the top collaborators of Laurie Herviou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurie Herviou. Laurie Herviou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vanoli, Fabio, Laurie Herviou, Yusuke Tsuda, et al.. (2023). Generating in vitro models of NTRK-fusion mesenchymal neoplasia as tools for investigating kinase oncogenic activation and response to targeted therapy. Oncogenesis. 12(1). 8–8. 6 indexed citations

Thomas, Morgane, Hugues de Boussac, Laure Vincent, et al.. (2023). Epigenetic Modifiers MMSET and EZH2 Physically Interact and Cooperate to Support Multiple Myeloma Pathophysiology. Blood. 142(Supplement 1). 1964–1964. 1 indexed citations

Ovejero, Sara, Laurie Herviou, Hugues de Boussac, et al.. (2022). Comprehensive characterization of the epigenetic landscape in Multiple Myeloma. Theranostics. 12(4). 1715–1729. 17 indexed citations

Dermawan, Josephine K., Fabio Vanoli, Laurie Herviou, et al.. (2022). Comprehensive genomic profiling of EWSR1/FUS::CREB translocation-associated tumors uncovers prognostically significant recurrent genetic alterations and methylation-transcriptional correlates. Modern Pathology. 35(8). 1055–1065. 24 indexed citations

Kassambara, Alboukadel, Laurie Herviou, Sara Ovejero, et al.. (2021). RNA-sequencing data-driven dissection of human plasma cell differentiation reveals new potential transcription regulators. Leukemia. 35(5). 1451–1462. 26 indexed citations

Vanoli, Fabio, Laurie Herviou, Yun‐Shao Sung, et al.. (2021). Generation of human embryonic stem cell models to exploit the EWSR1-CREB fusion promiscuity as a common pathway of transformation in human tumors. Oncogene. 40(32). 5095–5104. 11 indexed citations

Herviou, Laurie, Sara Ovejero, Claire Gourzonès, et al.. (2021). Targeting the methyltransferase SETD8 impairs tumor cell survival and overcomes drug resistance independently of p53 status in multiple myeloma. Clinical Epigenetics. 13(1). 174–174. 19 indexed citations

Manzari, Mandana T., Laurie Herviou, Katia Manova‐Todorova, et al.. (2020). Tumor-targeted nanoparticles improve the therapeutic index of BCL2 and MCL1 dual inhibition. Blood. 137(15). 2057–2069. 27 indexed citations

Herviou, Laurie, Hugues de Boussac, Giorgio L. Papadopoulos, et al.. (2020). Comprehensive Characterization of the Epigenetic Landscape in Multiple Myeloma. Blood. 136(Supplement 1). 2–3. 3 indexed citations

10.

Herviou, Laurie, Michel Jourdan, Anne‐Marie Martinez, Giacomo Cavalli, & Jérôme Moreaux. (2019). EZH2 is overexpressed in transitional preplasmablasts and is involved in human plasma cell differentiation. Leukemia. 33(8). 2047–2060. 37 indexed citations

11.

Herviou, Laurie, Giacomo Cavalli, & Jérôme Moreaux. (2018). Rôle de EZH2 comme biomarqueur dans le traitement personnalisé du myélome multiple. Bulletin du Cancer. 105(9). 804–819. 4 indexed citations

12.

Herviou, Laurie, Alboukadel Kassambara, Stéphanie Boireau, et al.. (2018). PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs. Clinical Epigenetics. 10(1). 121–121. 32 indexed citations

13.

Bruyer, Angélique, Ken Maes, Laurie Herviou, et al.. (2018). DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells. British Journal of Cancer. 118(8). 1062–1073. 32 indexed citations

14.

Kassambara, Alboukadel, et al.. (2017). RNA Sequencing Data-Driven Dissection of Human Plasma Cell Differentiation Reveals New Potential Transcription Regulators. Blood. 130. 4382–4382. 2 indexed citations

15.

Herviou, Laurie, Alboukadel Kassambara, Stéphanie Boireau, et al.. (2016). Targeting EZH2 in Multiple Myeloma Could be Promising for a Subgroup of MM Patients in Combination with IMiDs. Blood. 128(22). 311–311. 9 indexed citations

16.

Sexton, Tom, Thierry Gostan, Laurie Herviou, et al.. (2015). Distinct polymer physics principles govern chromatin dynamics in mouse and Drosophila topological domains. BMC Genomics. 16(1). 607–607. 10 indexed citations

17.

Herviou, Laurie, Anja Seckinger, Nicolas Robert, et al.. (2015). Inhibition of H3K9 methyltransferase as a potent therapeutic target in multiple myeloma. Clinical Lymphoma Myeloma & Leukemia. 15. e214–e215. 1 indexed citations

18.

Herviou, Laurie, Anja Seckinger, Hartmut Goldschmidt, et al.. (2015). Inhibition of SUV39H Methyltransferase As a Potent Therapeutic Target in Multiple Myeloma. Blood. 126(23). 1771–1771. 4 indexed citations

19.

Herviou, Laurie, Giacomo Cavalli, Guillaume Cartron, Bernard Klein, & Jérôme Moreaux. (2015). EZH2 in normal hematopoiesis and hematological malignancies. Oncotarget. 7(3). 2284–2296. 78 indexed citations

20.

Bittencourt, Danielle, Dai‐Ying Wu, Kwang Won Jeong, et al.. (2012). G9a functions as a molecular scaffold for assembly of transcriptional coactivators on a subset of Glucocorticoid Receptor target genes. Proceedings of the National Academy of Sciences. 109(48). 19673–19678. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact